Dolby Laboratories, Inc.Class A (DLB) is a publicly traded Technology sector company. As of May 20, 2026, DLB trades at $53.50 with a market cap of $5.14B and a P/E ratio of 21.34. DLB moved +0.34% today. Year to date, DLB is -15.99%; over the trailing twelve months it is -30.63%. Its 52-week range spans $53.20 to $89.66. Analyst consensus is strong buy with an average price target of $87.50. Rallies surfaces DLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DLB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DLB recently traded at $53.50. Market cap is $5.14B. P/E ratio is 21.34. Revenue is $1.34B.
| Metric | Value |
|---|---|
| Price | $53.50 |
| Market Cap | $5.14B |
| P/E Ratio | 21.34 |
| EPS | $2.51 |
| Dividend Yield | 0.36% |
| 52-Week High | $89.66 |
| 52-Week Low | $53.20 |
| Volume | 324.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.34B |
| Net Income | $242.10M |
| Gross Margin | 87.86% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.35B | $256.49M | $2.66 |
| 2024 | $1.27B | $264.32M | $2.74 |
| 2023 | $1.30B | $201.64M | $2.10 |
| 2022 | $1.25B | $183.90M | $1.84 |
3 analysts cover DLB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.50.